U.S. flag

An official website of the United States government

NM_000097.7(CPOX):c.995G>A (p.Arg332Gln) AND not provided

Germline classification:
Conflicting interpretations of pathogenicity (3 submissions)
Last evaluated:
Aug 1, 2024
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000522440.11

Allele description [Variation Report for NM_000097.7(CPOX):c.995G>A (p.Arg332Gln)]

NM_000097.7(CPOX):c.995G>A (p.Arg332Gln)

Gene:
CPOX:coproporphyrinogen oxidase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3q11.2
Genomic location:
Preferred name:
NM_000097.7(CPOX):c.995G>A (p.Arg332Gln)
HGVS:
  • NC_000003.12:g.98585618C>T
  • NG_015994.2:g.12994G>A
  • NM_000097.7:c.995G>AMANE SELECT
  • NP_000088.3:p.Arg332Gln
  • LRG_1077t1:c.995G>A
  • LRG_1077:g.12994G>A
  • LRG_1077p1:p.Arg332Gln
  • NC_000003.11:g.98304462C>T
  • NM_000097.5:c.995G>A
Protein change:
R332Q
Links:
dbSNP: rs781627991
NCBI 1000 Genomes Browser:
rs781627991
Molecular consequence:
  • NM_000097.7:c.995G>A - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000617838GeneDx
criteria provided, single submitter

(GeneDx Variant Classification (06012015))
Uncertain significance
(Sep 14, 2017)
germlineclinical testing

Citation Link,

SCV000963765Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Dec 31, 2023)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

SCV005330415CeGaT Center for Human Genetics Tuebingen
criteria provided, single submitter

(CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2)
Uncertain significance
(Aug 1, 2024)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes1not providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Hereditary coproporphyria: report of an Irish kindred and identification of a novel gene mutation.

Gorman CS, Gill D, Darby C, Crowley V, Mahony MJ.

Ir Med J. 2008 Apr;101(4):125. No abstract available.

PubMed [citation]
PMID:
18557518

Co-existence of hereditary coproporphyria and porphyria cutanea tarda: The importance of genetic testing.

Rudd A, Grant J, Varigos G, Morgan V, Winship I.

Australas J Dermatol. 2013 May;54(2):e50-2. doi: 10.1111/j.1440-0960.2011.00875.x. Epub 2012 Mar 21.

PubMed [citation]
PMID:
23582006
See all PubMed Citations (3)

Details of each submission

From GeneDx, SCV000617838.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The R332Q variant was identified in two unrelated families with clinical and biochemical features suggestive of hereditary coproporphyria (HCP) (Gorman et al., 2008; Ma et al., 2011). In both families, the R332Q variant was identified in several individuals with acute episodes of porphyria symptoms, some of whom responded to treatment with heme arginate infusions, and was also detected in unaffected family members (Gorman et al., 2008; Ma et al., 2011; Rudd et al., 2013). The R332Q variant is not observed at significance frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). It is a semi-conservative amino acid substitution that occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. Based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000963765.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 332 of the CPOX protein (p.Arg332Gln). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with coproporphyria (PMID: 18557518, 23582006; Invitae). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 449558). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CPOX protein function with a positive predictive value of 80%. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From CeGaT Center for Human Genetics Tuebingen, SCV005330415.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testingnot provided

Description

CPOX: PM5, PP3

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided1not providednot providednot provided

Last Updated: Oct 20, 2024